Immunocore, EORTC announce enrollment of first patient in Phase 3 ATOM trial

The European Organisation for Research and Treatment of Cancer and Immunocore (IMCR) Holdings announced the randomization of the first...
4 days ago
from: Yahoo Finance

European Organisation for Research and Treatment of Cancer, Eye neoplasm, Immunocore, Oncology, Uvea, Uveal melanoma

More about this

- Immunocore, EORTC announce enrollment of first patient in Phase 3 ATOM trial
The European Organisation for Research and Treatment of Cancer and Immunocore (IMCR) Holdings announced the randomization of the first...
from: Yahoo Finance

- Immunocore Launches Groundbreaking Phase 3 Trial for Uveal Melanoma Prevention with Tebentafusp
Immunocore (NASDAQ: IMCR) and EORTC have initiated the first Phase 3 Adjuvant Trial in Ocular Melanoma (ATOM), enrolling their first patient...
from: Stock Titan